Product Information
METRONIDAZOLE VAGINAL 0.75% GL is a generic product labeled by Saptalis Pharmaceuticals LLC, priced at $0.1413 per GM under NDC 71656006770. Its NADAC has been published 59 times since Jul 9, 2025.
FDA first approved this application on Dec 31, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/g
Manufacturer
Saptalis Pharmaceuticals LLCNDC
71656006770
Classification
Generic
Dosage Form
GEL
Route
VAGINAL
Effective Date
8/19/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA216750FDA Approved
12/31/2024
TE Code
AB
On Market Since
3/3/2025
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE VAGINAL 0.75% GL has been published 59 times since Jul 9, 2025, and over the history we have for it it has declined 32.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1413 per GM |
|---|---|
| All-time high | $0.2091 (Jul 16, 2025) |
| All-time low | $0.1405 (Jul 22, 2026) |
| 52-week high | $0.1888 |
| 52-week low | $0.1405 |
| Median price | $0.1810 |
| Average price | $0.1724 |
| Largest weekly change | -10.4% (Jul 23, 2025) |
| Weeks tracked | 59 |
| Tracking since | Jul 9, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METRONIDAZOLE VAGINAL 0.75% GL?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE VAGINAL 0.75% GL, manufactured by Saptalis Pharmaceuticals LLC, is $0.1413 per GM (NDC 71656006770), effective Aug 19, 2026.
How has the price of METRONIDAZOLE VAGINAL 0.75% GL changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE VAGINAL 0.75% GL has declined 32.4%. It has been tracked across 59 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE VAGINAL 0.75% GL?
Since Jul 9, 2025, the NADAC for METRONIDAZOLE VAGINAL 0.75% GL has ranged from a low of $0.1405 (Jul 22, 2026) to a high of $0.2091 (Jul 16, 2025), with a median of $0.1810 per GM.
Are there cheaper alternatives to METRONIDAZOLE VAGINAL 0.75% GL?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METRONIDAZOLE VAGINAL 0.75% GL in a comparable dosage form, but none are currently priced below it.
Who manufactures METRONIDAZOLE VAGINAL 0.75% GL?
METRONIDAZOLE VAGINAL 0.75% GL (NDC 71656006770) is labeled by Saptalis Pharmaceuticals LLC, and CMS classifies it as a generic product.